Identification of Inhibitors of Thrombospondin 1 Activation of TGF-β.


Journal

ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073

Informations de publication

Date de publication:
11 Jun 2020
Historique:
received: 21 11 2019
accepted: 07 05 2020
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 20 6 2020
Statut: epublish

Résumé

TGF-β has been a target of interest for the treatment of fibrotic diseases and certain cancers. Approaches to target TGF-β include antagonists of the active ligand or TGF-β receptor kinase activity. These approaches have failed in clinical trials due to a lack of effectiveness and a limited therapeutic window. In this context, newer and more selective approaches to target TGF-β are needed. We previously reported that the matricellular protein, thrombospondin 1, activates the latent TGF-β complex and that antagonism of this pathway using tri/tetrapeptides in various animal models reduces fibrosis. The tripeptide, SRI-31277 (

Identifiants

pubmed: 32550992
doi: 10.1021/acsmedchemlett.9b00540
pmc: PMC7294719
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1130-1136

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK079626
Pays : United States

Informations de copyright

Copyright © 2020 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Cold Spring Harb Perspect Biol. 2017 Oct 3;9(10):
pubmed: 28246179
J Biol Chem. 1999 Jan 1;274(1):430-7
pubmed: 9867861
Matrix Biol. 2018 Aug;68-69:28-43
pubmed: 29288716
J Biol Chem. 1999 May 7;274(19):13586-93
pubmed: 10224129
Curr Pharm Des. 2012;18(27):4126-34
pubmed: 22630082
J Transl Med. 2012 Sep 03;10:183
pubmed: 22943793
Am J Pathol. 2016 Mar;186(3):678-90
pubmed: 26801735
Matrix Biol. 2012 Apr;31(3):178-86
pubmed: 22266026
Respirology. 2018 Dec;23(12):1096-1097
pubmed: 30284753
Am J Pathol. 2011 Jun;178(6):2573-86
pubmed: 21641382
J Cell Biol. 2002 Oct 28;159(2):373-82
pubmed: 12391027
Am J Pathol. 2007 Sep;171(3):777-89
pubmed: 17640965
Biochemistry. 2002 Dec 3;41(48):14329-39
pubmed: 12450399

Auteurs

Mark J Suto (MJ)

Drug Discovery Division, Southern Research Institute, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States.

Vandana Gupta (V)

Drug Discovery Division, Southern Research Institute, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States.

Bini Mathew (B)

Drug Discovery Division, Southern Research Institute, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States.

Wei Zhang (W)

Drug Discovery Division, Southern Research Institute, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States.

Manuel A Pallero (MA)

Department of Pathology, University of Alabama at Birmingham, VH G001A, 1720 Second Avenue South, Birmingham, Alabama 35294, United States.

Joanne E Murphy-Ullrich (JE)

Department of Pathology, University of Alabama at Birmingham, VH G001A, 1720 Second Avenue South, Birmingham, Alabama 35294, United States.

Classifications MeSH